BRPI0307816B8 - composição farmacêutica oral líquida adequada como uma composição de carga líquida para uma forma de dosagem de cápsula macia - Google Patents

composição farmacêutica oral líquida adequada como uma composição de carga líquida para uma forma de dosagem de cápsula macia

Info

Publication number
BRPI0307816B8
BRPI0307816B8 BRPI0307816A BR0307816A BRPI0307816B8 BR PI0307816 B8 BRPI0307816 B8 BR PI0307816B8 BR PI0307816 A BRPI0307816 A BR PI0307816A BR 0307816 A BR0307816 A BR 0307816A BR PI0307816 B8 BRPI0307816 B8 BR PI0307816B8
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
soft capsule
liquid
dosage form
oral pharmaceutical
Prior art date
Application number
BRPI0307816A
Other languages
English (en)
Other versions
BR0307816C1 (pt
BRPI0307816B1 (pt
BR0307816A (pt
Inventor
Leverd Elie
Bougaret Joel
Bohn Marie-Madeleine
Heintz Norbert
Original Assignee
R P Scherer Tech Inc
Scherer Technologies Llc R P
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29715700&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0307816(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CA002388431A external-priority patent/CA2388431C/en
Priority claimed from US10/161,454 external-priority patent/US6890558B2/en
Priority claimed from FR0206886A external-priority patent/FR2840203B1/fr
Application filed by R P Scherer Tech Inc, Scherer Technologies Llc R P filed Critical R P Scherer Tech Inc
Publication of BR0307816A publication Critical patent/BR0307816A/pt
Publication of BR0307816C1 publication Critical patent/BR0307816C1/pt
Publication of BRPI0307816B1 publication Critical patent/BRPI0307816B1/pt
Publication of BRPI0307816B8 publication Critical patent/BRPI0307816B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"composição farmacêutica oral para cápsulas macias contendo vinorelbina e método de tratamento". a invenção descrita aqui refere-se a uma composição farmacêutica contendo vinorelbina como um ingrediente ativo que é adequado para encapsulação em cápsulas macias. a composição farmacêutica oral líquida adequada para a composição de carga líquida para uma forma de dosagem de cápsula macia compreende: vinorelbina ou um sal farmaceuticamente aceitável deste; etanol; água; glicerol; e polietileno glicol. na modalidade preferida, a forma de sal de tartrato de vinorelbina é empregada na composição. a invenção também prover a subsistência de um método para tratar câncer compreendendo oralmente administrar, a um paciente em necessidade de tal tratamento, uma cápsula macia compreendendo a composição farmacêutica da invenção.
BRPI0307816A 2002-05-31 2003-05-28 composição farmacêutica oral líquida adequada como uma composição de carga líquida para uma forma de dosagem de cápsula macia BRPI0307816B8 (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
FR0206886 2002-05-31
CA002388431A CA2388431C (en) 2002-05-31 2002-05-31 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
US10/161,454 US6890558B2 (en) 2002-05-31 2002-05-31 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
CA2,388,431 2002-05-31
US10/161,454 2002-05-31
FR0206886A FR2840203B1 (fr) 2002-05-31 2002-05-31 Composition pharmaceutique orale pour capsules molles contenant vinorelbine et methode de traitement

Publications (4)

Publication Number Publication Date
BR0307816A BR0307816A (pt) 2005-08-02
BR0307816C1 BR0307816C1 (pt) 2006-09-19
BRPI0307816B1 BRPI0307816B1 (pt) 2018-03-06
BRPI0307816B8 true BRPI0307816B8 (pt) 2021-05-25

Family

ID=29715700

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0307816A BRPI0307816B8 (pt) 2002-05-31 2003-05-28 composição farmacêutica oral líquida adequada como uma composição de carga líquida para uma forma de dosagem de cápsula macia
BRC10307816A BRPI0307816F1 (pt) 2002-05-31 2006-05-26 Usos de uma composição de carga farmacêutica oral líquida para forma de dosagem de cápsula macia

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRC10307816A BRPI0307816F1 (pt) 2002-05-31 2006-05-26 Usos de uma composição de carga farmacêutica oral líquida para forma de dosagem de cápsula macia

Country Status (15)

Country Link
EP (1) EP1530459B1 (pt)
JP (2) JP4718170B2 (pt)
CN (1) CN1287794C (pt)
AT (1) ATE462419T1 (pt)
AU (1) AU2003240808B2 (pt)
BR (2) BRPI0307816B8 (pt)
CY (1) CY1110184T1 (pt)
DE (1) DE60331920D1 (pt)
DK (1) DK1530459T3 (pt)
ES (1) ES2343790T3 (pt)
HK (1) HK1079421A1 (pt)
MX (1) MXPA04006054A (pt)
PT (1) PT1530459E (pt)
SI (1) SI1530459T1 (pt)
WO (1) WO2003101383A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2401992T3 (es) 2004-12-30 2013-04-26 Pierre Fabre Medicament Dispersión sólida estable de un derviado de alcaloide de vinca y procedimiento para su preparación
FR2880274B1 (fr) * 2004-12-30 2007-04-13 Pierre Fabre Medicament Sa Dispersion solide stable d'un derive d'alcaloides de vinca et son procede de fabrication
CN101134026B (zh) * 2006-08-31 2011-12-07 江苏豪森药业股份有限公司 长春瑞滨软胶囊及其制备方法和其应用
FR2918566B1 (fr) 2007-07-11 2009-10-09 Pierre Fabre Medicament Sa Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
FR2918567B1 (fr) * 2007-07-11 2012-08-03 Pf Medicament Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
WO2009105937A1 (zh) * 2008-02-29 2009-09-03 江苏豪森药业股份有限公司 长春瑞滨软胶囊及其制备方法和其应用
CA3014473A1 (en) 2016-03-09 2017-09-14 Synbias Pharma Ag Vinorelbine monotartrate and its pharmaceutical use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4623629A (en) * 1983-10-31 1986-11-18 Daniel Kerschensteiner Solid-phase immunoassay support and method of use thereof
US5447936A (en) * 1993-12-22 1995-09-05 Bionumerik Pharmaceuticals, Inc. Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
US5641512A (en) * 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
DE19545043A1 (de) * 1995-12-02 1997-06-05 Scherer Gmbh R P Pharmazeutische Präparate zur oralen Anwendung und Verfahren zu ihrer Herstellung
JP4629238B2 (ja) * 1999-05-24 2011-02-09 サザン・リサーチ・インスティテュート イソホスホアミドマスタード・アナログ及びその使用

Also Published As

Publication number Publication date
AU2003240808A1 (en) 2003-12-19
ATE462419T1 (de) 2010-04-15
BR0307816C1 (pt) 2006-09-19
CN1287794C (zh) 2006-12-06
MXPA04006054A (es) 2004-09-27
JP4718170B2 (ja) 2011-07-06
JP2010280739A (ja) 2010-12-16
HK1079421A1 (en) 2006-04-07
WO2003101383A2 (en) 2003-12-11
BRPI0307816B1 (pt) 2018-03-06
JP2006516111A (ja) 2006-06-22
JP5334937B2 (ja) 2013-11-06
ES2343790T3 (es) 2010-08-10
CY1110184T1 (el) 2015-01-14
EP1530459A2 (en) 2005-05-18
CN1638745A (zh) 2005-07-13
DK1530459T3 (da) 2010-07-19
BRPI0307816F1 (pt) 2022-02-15
EP1530459B1 (en) 2010-03-31
SI1530459T1 (sl) 2010-08-31
PT1530459E (pt) 2010-05-20
DE60331920D1 (de) 2010-05-12
AU2003240808B2 (en) 2008-05-08
EP1530459A4 (en) 2007-08-22
WO2003101383A3 (en) 2004-09-30
BR0307816A (pt) 2005-08-02

Similar Documents

Publication Publication Date Title
RU2356547C2 (ru) Способы лечения рака с использованием ингибиторов hdac
WO2018005695A1 (en) Use of neurokinin-1 antagonists to treat a variety of pruritic conditions
BRPI0307816F1 (pt) Usos de uma composição de carga farmacêutica oral líquida para forma de dosagem de cápsula macia
EA200601253A1 (ru) Преимущественно линейная шипучая лекарственная форма фентанила для перорального применения и способы введения
EA200600820A1 (ru) Способы лечения, модификации и устранения боли с использованием 1-оксо-2-(2,6-диоксопиперидин-3-ил)-4-метилизоиндолина
NZ605887A (en) Pharmaceutical dosage form comprising 6’-fluoro-(n-methyl- or n,n-dimethyl-)-4-phenyl-4’,9’-dihydro-3’h-spiro[cyclohexane-1,1’-pyrano[3,4,b]indol]-4-amine for the treatment of neuropathic pain
US20040258740A1 (en) Transdermal delivery composition
RU2003116058A (ru) Композиции гидрокодона с контролируемым высвобождением
CA2434484A1 (en) Compositions comprising ibuprofen and diphenhydramine to treat pain-associated sleep disturbances
BRPI0707235B1 (pt) formulação de fentanil sublingual sem propelente, e, dispositivo de dose unitária para administração sublingual de uma formulação de fentanil sublingual
HRP20050544A2 (en) Solid drug for oral use
EP1708685A4 (en) GALENIC FORMS OF EFFERVESCENT ORAL OPIATES AND METHODS OF ADMINISTERING OPIATES
AR075735A1 (es) Composiciones farmaceuticas de liberacion inmediata que comprenden oxicodona y naloxona. uso
HUE029677T2 (hu) Készítmények centrálisan mediált émelygés és hányás kezelésére
KR20060126555A (ko) 피부학적 연질 겔 조성물
CO5580741A2 (es) Composicion farmaceutica que comprende un agonista de receptor de 5ht1
RU2010109359A (ru) Азитромицин для лечения кожных заболеваний
MXPA04004907A (es) Composiciones de acetaminofen.
HN2001000038A (es) Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina
JP2012041314A5 (pt)
CA2388431A1 (en) Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
DK2091520T3 (da) Oral doseringsform omfattende trisubstituerede glycerol-forbindelser
WO2020023898A1 (en) Use of neurokinin-1 antagonists to treat chronic pruritus
MX2010006310A (es) O-desmetil-venlafaxina para el tratamiento de transtorno depresivo mayor.
RU2020108631A (ru) Новая вспомогательная терапия для применения в способе лечения рака простаты

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: "PARA: INT. CL. A61K 9/48

Ipc: A61K 9/48 (2011.01), A61P 35/00 (2011.01)

Free format text: PARA: INT. CL. A61K 9/48; A61P 35/00

Ipc: A61K 9/48 (2011.01), A61P 35/00 (2011.01)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B25D Requested change of name of applicant approved
B25G Requested change of headquarter approved
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/05/2003 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B09A Decision: intention to grant [chapter 9.1 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE:

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/05/2003, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: ADDITIONAL INVENTOR'S CERTIFICATE: REFERENTE A 21A ANUIDADE.